China: Recent research published in Diabetes, Metabolic Syndrome and Obesity suggests that lower levels of free ...

Building on preclinical success demonstrating age reversal, longevity, and increased healthspan, Telomir-1 appears to address ...

Rybelsus in combination with standard T2DM therapy reduced the risk of major cardiovascular events by 14% in patients with ...

A randomized controlled trial found that carrageenan, a common food additive, may cause subclinical inflammation and insulin ...

Shares of Telomir Pharmaceuticals climbed up 20% to $5.10 after the company said it saw positive pre-clinical results confirming the efficacy of its licensed molecule Telomir-1 in reversing several ...

The study, published in the journal Medicine, suggests that ertugliflozin, a medication from the sodium-glucose ...

(HealthDay News) — Younger age at diagnosis of type 2 diabetes is significantly associated with a higher risk for subsequent dementia, according to a study published online in PLOS ONE.